Squarepoint’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,071
| Closed | -$109K | – | 3038 |
|
|
2024
Q4 | $109K | Sell |
28,071
-14,724
| -34% | -$57K | ﹤0.01% | 2524 |
|
|
2024
Q3 | $280K | Buy |
42,795
+12,937
| +43% | +$84.7K | ﹤0.01% | 2037 |
|
|
2024
Q2 | $216K | Buy |
+29,858
| New | +$216K | ﹤0.01% | 2116 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2704 |
|
|
2023
Q2 | – | Sell |
-30,655
| Closed | -$139K | – | 2648 |
|
|
2023
Q1 | $139K | Buy |
+30,655
| New | +$139K | ﹤0.01% | 1963 |
|
|
2020
Q2 | – | Sell |
-865
| Closed | -$8K | – | 2317 |
|
|
2020
Q1 | $8K | Sell |
865
-2,137
| -71% | -$19.8K | ﹤0.01% | 1777 |
|
|
2019
Q4 | $40K | Buy |
+3,002
| New | +$40K | ﹤0.01% | 2312 |
|
|
2019
Q2 | – | Sell |
-1,542
| Closed | -$51K | – | 2465 |
|
|
2019
Q1 | $51K | Sell |
1,542
-5,321
| -78% | -$176K | ﹤0.01% | 2029 |
|
|
2018
Q4 | $408K | Buy |
6,863
+2,938
| +75% | +$175K | ﹤0.01% | 1346 |
|
|
2018
Q3 | $551K | Buy |
3,925
+2,867
| +271% | +$402K | 0.01% | 1253 |
|
|
2018
Q2 | $130K | Buy |
+1,058
| New | +$130K | ﹤0.01% | 1617 |
|
|
2018
Q1 | – | Sell |
-1,575
| Closed | -$87K | – | 1933 |
|
|
2017
Q4 | $87K | Sell |
1,575
-2,292
| -59% | -$127K | ﹤0.01% | 1965 |
|
|
2017
Q3 | $163K | Buy |
3,867
+2,870
| +288% | +$121K | ﹤0.01% | 1423 |
|
|
2017
Q2 | $42K | Buy |
+997
| New | +$42K | ﹤0.01% | 1458 |
|
|
2017
Q1 | – | Sell |
-904
| Closed | -$35K | – | 1732 |
|
|
2016
Q4 | $35K | Buy |
+904
| New | +$35K | ﹤0.01% | 1711 |
|
|
2016
Q2 | – | Sell |
-5,708
| Closed | -$458K | – | 1244 |
|
|
2016
Q1 | $458K | Buy |
5,708
+4,241
| +289% | +$340K | 0.04% | 659 |
|
|
2015
Q4 | $111K | Buy |
+1,467
| New | +$111K | 0.01% | 1122 |
|